BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

Momenta, Virdante Pharmaceuticals deal

Momenta acquired Virdante's Sialic Switch assets, including IP and cell lines, relating to the sialylation of IV immunoglobulin ( IVIG) and other proteins for $4.5 million up front in cash. Virdante is eligible for an additional $51.5 million...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >